|
|
Blood, 15 July 2005, Vol. 106, No. 2, pp. 444-446.
Prepublished online as a Blood First Edition Paper on March 31, 2005; DOI 10.1182/blood-2004-11-4353.
 Previous Article | Table of Contents | Next Article 
CHEMOKINES
Brief report
Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules
Hege S. Carlsen,
Guttorm Haraldsen,
Per Brandtzaeg, and
Espen S. Baekkevold
From the Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), Institute and Department of Pathology, University of Oslo, Rikshospitalet University Hospital, Norway; and the Department of Surgery, University of Oslo, Rikshospitalet University Hospital, Norway
T-cell homing to secondary lymphoid tissues generally depends on chemokine-induced firm adhesion in high endothelial venules (HEVs) and is primarily mediated through the CC chemokine receptor 7 (CCR7) on lymphocytes. The CCR7 ligand designated CCL21 is considered the most important trigger because it appears constitutively expressed by murine HEVs. Surprisingly, when we analyzed human tissues, no CCL21 mRNA could be detected in HEVs. In fact, CCL21 mRNA was only expressed in extravascular T-zone cells and lymphatics, whereas immunostaining revealed CCL21 protein within HEVs. This suggests that T-cell recruitment to human lymphoid tissues depends on the transcytosis of lymphoid chemokines through HEV cells because there is at present no evidence of alternative chemokine production in these cells that could explain the attraction of naive T lymphocytes.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Manzo, S. Bugatti, R. Caporali, R. Prevo, D. G. Jackson, M. Uguccioni, C. D. Buckley, C. Montecucco, and C. Pitzalis
CCL21 Expression Pattern of Human Secondary Lymphoid Organ Stroma Is Conserved in Inflammatory Lesions with Lymphoid Neogenesis
Am. J. Pathol.,
November 1, 2007;
171(5):
1549 - 1562.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Unsoeld, K. Mueller, U. Schleicher, C. Bogdan, J. Zwirner, D. Voehringer, and H. Pircher
Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections
Int. Immunol.,
November 1, 2007;
19(11):
1281 - 1289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ame-Thomas, H. Maby-El Hajjami, C. Monvoisin, R. Jean, D. Monnier, S. Caulet-Maugendre, T. Guillaudeux, T. Lamy, T. Fest, and K. Tarte
Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis
Blood,
January 15, 2007;
109(2):
693 - 702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Otero, M. Groettrup, and D. F. Legler
Opposite Fate of Endocytosed CCR7 and Its Ligands: Recycling versus Degradation
J. Immunol.,
August 15, 2006;
177(4):
2314 - 2323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Sanchez-Sanchez, L. Riol-Blanco, and J. L. Rodriguez-Fernandez
The Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells
J. Immunol.,
May 1, 2006;
176(9):
5153 - 5159.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
